drugset / Trial / NCT02144987

Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy

NCT02144987 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Bone Marrow Stem Cell transplantation may improve Assisted Reproduction Techniques (ART) outcomes in refractive Asherman's Syndrome or Atrophic Endometrium.

Timeline

Start
2013-04
Primary completion
2014-09
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CD133+ bone marrow-derived stem cells Cell therapy 5e+07 cells Other
Background Bone Marrow CD133+ Stem Cell Transplantation Unknown 5 ug/kg Subcutaneous

Indications